SCYNEXIS, Inc.

Home » SCYNEXIS, Inc.

Secondary

SCYNEXIS, Inc.

SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies.

Symbol

SCYX

Last Closing Price
$1.65

Shares
TBD

Anticipated Date
TBD

Underwriters
Guggenheim Securities

To view the prospectus for SCYNEXIS, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253